CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients.
about
Human leukocyte antigens and HIV type 1 viral load in early and chronic infection: predominance of evolving relationshipsHIV-1 Env C2-V4 diversification in a slow-progressor infant reveals a flat but rugged fitness landscapeEfficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cellsDefining epitope coverage requirements for T cell-based HIV vaccines: theoretical considerations and practical applications.HIV-1 group M conserved elements vaccine.Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads.Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical statusPhylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag.Host HLA B*allele-associated multi-clade Gag T-cell recognition correlates with slow HIV-1 disease progression in antiretroviral therapy-naïve Ugandans.Timing constraints of in vivo gag mutations during primary HIV-1 subtype C infectionHLA-associated immune pressure on Gag protein in CRF01_AE-infected individuals and its association with plasma viral load.Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigensPhase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidateIgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines.Genetic characteristics, coreceptor usage potential and evolution of Nigerian HIV-1 subtype G and CRF02_AG isolates.Dynamics and timing of in vivo mutations at Gag residue 242 during primary HIV-1 subtype C infection.The use of directed evolution to create a stable and immunogenic recombinant BCG expressing a modified HIV-1 Gag antigenImmunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents.Unique CRF01_AE Gag CTL epitopes associated with lower HIV-viral load and delayed disease progression in a cohort of HIV-infected Thais.Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.Immunity to HIV in Early LifeIntra- and inter-clade cross-reactivity by HIV-1 Gag specific T-cells reveals exclusive and commonly targeted regions: implications for current vaccine trialsViral and host factors associated with the HIV-1 viral load setpoint in adults from Mbeya Region, Tanzania.Impact of MHC class I diversity on immune control of immunodeficiency virus replication.Fluidity of HIV-1-specific T-cell responses during acute and early subtype C HIV-1 infection and associations with early disease progression.Pathogenesis and treatment of HIV infection: the cellular, the immune system and the neuroendocrine systems perspective.Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease.HIV-1 Subtype C Phylodynamics in the Global EpidemicADP ribosylation factor 1 activity is required to recruit AP-1 to the major histocompatibility complex class I (MHC-I) cytoplasmic tail and disrupt MHC-I trafficking in HIV-1-infected primary T cells.Evolutionary gamut of in vivo Gag substitutions during early HIV-1 subtype C infection.Broad and persistent Gag-specific CD8+ T-cell responses are associated with viral control but rarely drive viral escape during primary HIV-1 infectionClinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection.Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunityHuman immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set pointSIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection.Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection.Human immunodeficiency virus type 1 specific cytotoxic T lymphocyte responses in Chinese infected with HIV-1 B'/C Recombinant (CRF07_BC)Multi-layered Gag-specific immunodominant responses contribute to improved viral control in the CRF01_AE subtype of HIV-1-infected MSM subjects.A Generalized Entropy Measure of Within-Host Viral Diversity for Identifying Recent HIV-1 Infections
P2860
Q28394085-EEE58ECA-92FE-4DD5-B68E-FFE65E18668DQ28487168-C4395E9F-04A0-41ED-9BBE-2EA73F0167ABQ28748976-5A50994C-987C-4A1C-A4E4-4301936A218BQ30410411-24354789-3ECD-4C1D-8573-EB9A30372FCAQ33308246-9490501E-75CF-4B60-8D5E-F1E8D2725179Q33313878-F378E914-149F-4A50-9207-06C7093DC597Q33381538-8CAE1D25-B762-40C6-88E8-F0FB46CA7BA2Q33385995-2A456F78-8493-4445-A9DA-5A940FD6E882Q33399724-8E0CBF04-2C76-4018-A742-6A289F877ACFQ33515034-D81CCF98-6570-4DA1-B701-73343FA411CEQ33612214-1E669B7D-2F96-4CE7-9103-7015FB99791FQ33627613-3083D345-94E6-4722-8E05-03AEF28AD4BFQ33749950-A1E0FB50-768A-4AD4-A4C3-08B2A56E8CD4Q33827771-DD2D50E5-93A3-4C2E-9409-5EEDE1DB93E1Q33851789-D4FAEC82-A0E9-4539-8D3F-3A421B45823CQ33907924-75A7F1E5-57EA-43FD-93A9-FBAAC983FB77Q33952259-2C96BB8D-BD8D-452A-8371-9501F643F3A3Q33982883-E6F46089-A984-47E4-BD8E-77C501B83FB8Q33985956-9BA5E202-952F-4BFC-9A36-50F5EA85C2B3Q34007084-103A692B-5303-41AA-ABF0-B19513A36A18Q34033051-47C4D031-E0EE-4BEC-97A1-1BC4F3D5A4BAQ34055991-8E1B94FC-E249-4463-82C1-6E9441835143Q34216522-042608FB-046A-4F4C-B8A5-4B02AFAA178AQ34235198-6D1731D8-6BD7-4933-A719-CE331D13E4A1Q34295981-6A3994C1-0C3E-473F-BBD8-838ECCC65783Q34650866-DB2B7A0D-B9AB-4C94-82FB-390A7329FFD5Q34743627-5BECF00E-5C06-4A79-A896-AC6E25AAF77DQ35260218-EDF96478-6315-4735-B0BA-7CF41690D889Q35531422-17640DC1-F76A-48FF-B7A7-FDA9BD71D965Q35535663-4A16A2C6-05CF-48D7-B44B-A35FE1A847DDQ35592229-D3A01B66-0690-48A4-89BD-D0EF65EB0C60Q35641386-8DA7D011-E370-4C09-B751-E3A497DF1681Q35665770-7FD683A1-9E28-40A6-B9B2-78510F988600Q35680858-6C2EB386-2F89-4A58-B8CB-6B82FFFE3E81Q35857651-6A583900-92F7-4C3E-8D4D-C606DB4B9DDEQ35901710-DDB31625-0451-436F-8CC1-F5F43AB2DAD6Q35947590-C4E22EFE-542C-48C1-AE31-BF88AF9A6F33Q36059759-64CF1F41-48D4-46EE-B8B3-D91B115EABC8Q36117694-F1F21453-0BAE-4A6D-9F37-A6AF9B11EFA2Q36207177-705A9F01-983B-45DE-8591-DFB864824C30
P2860
CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
CD8 T-cell recognition of mult ...... type 1-seropositive patients.
@ast
CD8 T-cell recognition of mult ...... type 1-seropositive patients.
@en
type
label
CD8 T-cell recognition of mult ...... type 1-seropositive patients.
@ast
CD8 T-cell recognition of mult ...... type 1-seropositive patients.
@en
prefLabel
CD8 T-cell recognition of mult ...... type 1-seropositive patients.
@ast
CD8 T-cell recognition of mult ...... type 1-seropositive patients.
@en
P2093
P2860
P50
P356
P1433
P1476
CD8 T-cell recognition of mult ...... type 1-seropositive patients.
@en
P2093
Andreas Meyerhans
Antelmo Haule
Ellen Kuta
Eva Herrmann
Lilian Njovu
Oliver Hoffmann
Steffen Geis
P2860
P304
P356
10.1128/JVI.01847-06
P407
P50
P577
2006-12-20T00:00:00Z